Cargando…
New tricks for old targets: Anti-CTLA-4 antibodies re-envisioned for cancer immunotherapy
Autores principales: | Waight, Jeremy D., Chand, Dhan, Savitsky, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6101285/ https://www.ncbi.nlm.nih.gov/pubmed/30131845 http://dx.doi.org/10.18632/oncotarget.25800 |
Ejemplares similares
-
Re-engineering anti-CTLA-4 antibodies for enhancing cancer immunotherapy efficacy and safety
por: Seeruttun, Sharvesh Raj
Publicado: (2019) -
Next-generation CTLA-4 targeting molecules and combination therapy: promising strategies for improving cancer immunotherapy
por: Rudqvist, Nils-Petter, et al.
Publicado: (2023) -
Toxicological and pharmacological assessment of AGEN1884, a novel human IgG1 anti-CTLA-4 antibody
por: Gombos, Randi B., et al.
Publicado: (2018) -
C2 Re-envisioned
por: Vassiliou, Marius, et al.
Publicado: (2014) -
New Tricks by an Old Dog
por: Forst, Thomas, et al.
Publicado: (2008)